Metabolic Screening in Psychiatric Patients: Impact of a Quality Improvement Initiative
Aims: Metabolic syndrome is highly prevalent among psychiatric rehabilitation patients, with rates ranging from 40–60% globally. The condition significantly increases the risk of cardiovascular disease and type 2 diabetes, compounded by psychotropic medications, sedentary lifestyles, and poor dietar...
Saved in:
Main Author: | Ghulam Murtaza |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2025-06-01
|
Series: | BJPsych Open |
Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425106418/type/journal_article |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementing Patient-Initiated Follow-Up (PIFU) Into a Psychiatric Outpatient Setting
by: Thomas Scurr, et al.
Published: (2025-06-01) -
The Impact of Smoking Bans on Clozapine Metabolism and Psychiatric Stability: A Case Report
by: Praveen Kumar, et al.
Published: (2025-06-01) -
Audit on Drug Screening Practice on Inpatient Psychiatric Wards
by: Mohamed Hamid, et al.
Published: (2025-06-01) -
Ketogenic Metabolic Therapies for Psychiatric and Neurodevelopmental Disorders
by: Cristina Fante, et al.
Published: (2025-06-01) -
Quality of Life and Psychiatric Aspects in Epilepsy
by: Kutlu, Ayşe, et al.
Published: (2011)